BioCentury
ARTICLE | Clinical News

DecisionDx-Melanoma test: Data

June 17, 2013 7:00 AM UTC

Data from an independent validation study of 92 melanoma tumor samples showed that patients with tumors classified as Class 1 - low risk of metastasis - by Castle Biosciences' DecisionDx-Melanoma test...